University of Natural Resources and Life Sciences, Vienna (BOKU) - Research portal

Logo BOKU Resarch Portal


Search Items: Neutralization Tests - immunology, . hits: 9

** = Publications listed in SCI/SSCI - Journals (published in Web of Science)
* = peer-reviewed publication (not listed in SCI/SSCI)
Only: Full paper/article, Review, Proceedings Paper


** Haynes, BF; Fleming, J; St Clair, EW; Katinger, H; Stiegler, G; Kunert, R; Robinson, J; Scearce, RM; Plonk, K; Staats, HF; Ortel, TL; Liao, HX; Alam, SM Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies..

Science. 2005; 308(5730):1906-1908 WoS PubMed FullText FullText_BOKU

** Zwick, MB; Jensen, R; Church, S; Wang, M; Stiegler, G; Kunert, R; Katinger, H; Burton, DR Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1..

J Virol. 2005; 79(2):1252-1261 WoS PubMed PUBMED Central FullText FullText_BOKU


** Binley, JM; Wrin, T; Korber, B; Zwick, MB; Wang, M; Chappey, C; Stiegler, G; Kunert, R; Zolla-Pazner, S; Katinger, H; Petropoulos, CJ; Burton, DR Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies..

J Virol. 2004; 78(23):13232-13252 WoS PubMed PUBMED Central FullText FullText_BOKU

** Zwick, MB; Komori, HK; Stanfield, RL; Church, S; Wang, M; Parren, PW; Kunert, R; Katinger, H; Wilson, IA; Burton, DR The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5..

J Virol. 2004; 78(6):3155-3161 WoS PubMed PUBMED Central FullText FullText_BOKU


** Kunert, RE; Weik, R; Ferko, B; Stiegler, G; Katinger, H Anti-idiotypic antibody Ab2/3H6 mimics the epitope of the neutralizing anti-HIV-1 monoclonal antibody 2F5..

AIDS. 2002; 16(4):667-668 WoS PubMed


** Parker, CE; Deterding, LJ; Hager-Braun, C; Binley, JM; Schülke, N; Katinger, H; Moore, JP; Tomer, KB Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5..

J Virol. 2001; 75(22):10906-10911 WoS PubMed PUBMED Central FullText FullText_BOKU


** Trkola, A; Purtscher, M; Muster, T; Ballaun, C; Buchacher, A; Sullivan, N; Srinivasan, K; Sodroski, J; Moore, JP; Katinger, H Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1..

J Virol. 1996; 70(2):1100-1108 WoS PubMed PUBMED Central FullText


** Muster, T; Ferko, B; Klima, A; Purtscher, M; Trkola, A; Schulz, P; Grassauer, A; Engelhardt, OG; García-Sástre, A; Palese, P Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus..

J Virol. 1995; 69(11):6678-6686 WoS PubMed PUBMED Central FullText


** Buchacher, A; Predl, R; Strutzenberger, K; Steinfellner, W; Trkola, A; Purtscher, M; Gruber, G; Tauer, C; Steindl, F; Jungbauer, A Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization..

AIDS Res Hum Retroviruses. 1994; 10(4):359-369 WoS PubMed

© BOKU Wien Imprint